Publications by authors named "Jean Baptiste Nousbaum"

Introduction: Surgical resection is the standard recommended treatment in localized pancreatic cancer. The benefit of neoadjuvant chemotherapy is still debated. The aim of this population-based study was to describe the pancreatic cancer surgical management.

View Article and Find Full Text PDF

Background: The impact of geographical accessibility on cancer survival has been investigated in few studies, with most research focusing on access to reference care centers, using overall mortality and limited to specific cancer sites. This study aims to examine the association of access to primary care with mortality in excess of patients with the 10 most frequent cancers in France, while controlling for socioeconomic deprivation.

Methods: This study included a total of 151,984 cases diagnosed with the 10 most common cancer sites in 21 French cancer registries between 2013 and 2015.

View Article and Find Full Text PDF

Background And Aims: To measure the impact of socio-economic environment on the incidence of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA).

Method: The study used data from the French Network of Cancer Registries (FRANCIM) between 2006 and 2016. Classification of patients into HCC and iCCA was performed according to the topographical and morphological codes of the 3rd edition of the International Classification of Diseases for Oncology.

View Article and Find Full Text PDF

Background: The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. The aims of this article are which follows: To gather the practices of hepatogastroenterologists or pulmonologists practitioners regarding the diagnosis and management of the hepatic hydrothorax.

Methods: Practitioners from 13 French- speaking countries were invited to answer an online questionnaire on the hepatic hydrothorax diagnosis and its management.

View Article and Find Full Text PDF
Article Synopsis
  • Resection is the primary treatment for pancreatic ductal adenocarcinoma (PDAC), and the volume of surgical cases at hospitals significantly affects post-operative mortality and survival rates.
  • A study analyzed 763 PDAC patients from 2000-2014, categorizing hospitals into low, medium, and high-volume centers, finding that high-volume centers led to better survival outcomes and lower post-operative mortality.
  • Factors like hospital surgical volume played a crucial role in survival differences, suggesting that improving patient management in hospitals can enhance outcomes for PDAC surgeries.
View Article and Find Full Text PDF

Background And Aims: A highly sensitive and specific point-of-care method for diagnosing spontaneous bacterial peritonitis (SBP) is currently lacking. The objective of the present study is to evaluate the diagnostic value of a rapid, easy-to-use, mid-infrared fiber evanescent wave spectroscopy (MIR-FEWS) method for ruling out SBP.

Patients And Methods: Cirrhotic patients ( = 256) at five centers in France were included for suspected SBP or for the scheduled evacuation of ascites fluid.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) screening using fecal immunochemical testing (FIT) aims to detect pre-symptomatic colorectal lesions and reduce CRC mortality.

Aims: The objectives of this study were to determine the FIT sensitivity for diagnosis of CRC, the impact of diagnostic circumstances on treatment and survival, and risk factors for interval cancer (IC).

Methods: This population-based study evaluated the 2016-2017 CRC screening campaign in Finistère, France.

View Article and Find Full Text PDF

Pancreatic cancer is associated with high mortality rates, and most cases are diagnosed at advanced stages. This study aimed to evaluate the prognostic factors for survival in pancreatic adenocarcinoma. Data from the Finistere registry of digestive database were used in this analysis.

View Article and Find Full Text PDF

Oncological strategies in the elderly population are debated. The objective of this study was to determine the predictive factors of survival in patients aged 80 years and older with metastatic colon cancer. Data from four digestive tumour registry databases were used in this analysis.

View Article and Find Full Text PDF

Importance: Although treatment and prognosis of synchronous liver metastases from colorectal cancer are relatively well known, a comparative description of the incidence, epidemiological features, and outcomes of synchronous and metachronous liver metastases is lacking. The difference in prognosis between patients with synchronous and metachronous liver metastases is controversial.

Objective: To investigate temporal patterns in the incidence and outcomes of synchronous vs metachronous liver metastases from colorectal cancer.

View Article and Find Full Text PDF
Article Synopsis
  • Survival rates for colon cancer patients have improved due to better treatments and the use of multidisciplinary team meetings (MDTm), but the organization of these meetings can still be optimized.
  • A study of 1,616 patients diagnosed between 2014 and 2016 found that 20.5% were not presented in MDTm, mainly due to factors like advanced age, poor condition, and superficial tumors.
  • Identifying these non-presentation factors can help target improvements in MDTm organization and ensure more comprehensive patient care.
View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) is the second leading cause of cancer death in France (17,712 annual deaths). However, this cancer is preventable in the majority of cases by the early detection of adenomas. In France, the organized screening for CRC relies on general practitioners (GPs).

View Article and Find Full Text PDF

Cholestatic itch is a disabling symptom that may be secondary to liver or biliary diseases. Management of cholestatic pruritus is complex. A systematic review and meta-analysis on the efficacy of treatments for cholestatic pruritus were performed.

View Article and Find Full Text PDF

A total of 2%-10% of patients with vascular liver disease (VLD) have paroxysmal nocturnal hemoglobinuria (PNH). Eculizumab reduces complement-mediated haemolytic activity in PNH. This study was aimed at assessing the impact of eculizumab on VLD outcome.

View Article and Find Full Text PDF

Aim: Oncological strategies in the elderly population are often debated. The objective of this study was to investigate the survival rates and prevalence of ostomy in elderly patients operated on for stage III and IV rectal cancers.

Methods: This retrospective multicentric population-based study included 151 patients aged ≥75 years with stage III and IV rectal adenocarcinoma who underwent surgery between 2007 and 2014.

View Article and Find Full Text PDF

Purpose: Oncological strategies in the elderly population are debated. The objective of this study was to assess the factors predictive of poor prognosis in elderly patients with stage III colon cancer.

Methods: A retrospective review of demographic, pathologic, treatment, and outcome data from 308 patients with stage III colon adenocarcinoma who had undergone surgery between 2007 and 2014 was conducted.

View Article and Find Full Text PDF

Objective: The aim of this study was to compare quality performance of the first colorectal cancer (CRC) screening campaigns (C) with the OC Sensor® Faecal Immunological Test (FIT) (C7 from 2016 to 2017) and the Hemoccult® guaiac-based test (C1 from 2004 to 2006).

Methods: The participation rate of the eligible population, screening fecal occult blood test (FOBT) performance indices, CRC and adenoma detection rate and time interval between test positivity and colonoscopy were studied.

Results: In C7, 35.

View Article and Find Full Text PDF

Aim: We aimed to study the prognostic value of , , mutations and microsatellite stable (MSS)/instable (MSI) in the field of colorectal cancer invading the (ie, pT1 colorectal cancer (CRC)).

Methods: We led a case-control study in tumour samples from 60 patients with pT1 CRC with (20 cases) and without (40 cases) metastatic evolution (5 years of follow-up) which were analysed for , , mutations (Idylla testing and next generation sequencing, NGS) and MSS/MSI status (Idylla testing and expression of mismatch repair (MMR) proteins using immunohistochemistry).

Results: mutations were encountered in 11/20 (55%) cases and 21/40 (52.

View Article and Find Full Text PDF
Article Synopsis
  • Small bowel cancer encompasses various types, and a study in France over the last 20 years aimed to analyze trends in incidence based on histology.
  • The study found that overall incidence rates are higher in men (1.46/100,000) compared to women (0.9/100,000), with adenocarcinoma being the most common type (38%) followed by neuroendocrine tumors (35%).
  • Incidences of all tumor types, except lymphoma in men, significantly increased over the 20 years, potentially linked to advancements in imaging techniques and the need to explore underlying predisposing factors contributing to these trends.
View Article and Find Full Text PDF

The therapeutic management of patients with endoscopic resection of colorectal cancer invading the submucosa (i.e. pT1 CRC) depends on the balance between the risk of cancer relapse and the risk of surgery-related morbidity and mortality.

View Article and Find Full Text PDF
Article Synopsis
  • This study looks at how doctors can tell if patients with early colorectal cancer (pT1 CRC) need more surgery by checking for cancer risks like lymph node invasion and tumor recurrence.
  • Two pathologists reviewed 163 cases from a database in France, looking at specific factors based on guidelines.
  • They found that using certain types of tests made it easier for doctors to agree on the risk levels, especially for lymphovascular invasion and tumor budding, which helps decide if additional surgery is necessary.
View Article and Find Full Text PDF

Because of their efficacy against numerous cancers, immune-checkpoint inhibitors (ICIs), anti-cytotoxic T-lymphocyte antigen-4, and anti-programmed cell death monoclonal antibodies are being used ever more often in oncology. However, some patients were excluded from clinical trials because of their comorbidities despite their potentially higher cancer frequencies, as is the case for immunocompromised patients. Areas covered: We analyzed reported preclinical and clinical information and evaluated the risk/benefit ratio for four immunocompromised populations: people living with human immunodeficiency virus (PLHs), solid-organ transplant recipients, recipients of hematopoietic stem-cell allografts, and patients with autoimmune diseases.

View Article and Find Full Text PDF